PIŚMIENNICTWO
1. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754
2. Eckersall PD, Bell R. Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine. Vet J. 2010;185(1):23-27. doi:10.1016/j.tvjl.2010.04.009
3. Chi-Hsuan S, Pin-Chen L, Chu-Ning H, Chi-Chung C. C-reactive protein as an efficient indicator monitoring and prognosing canine inflammatory diseases. Taiwan Vet J. 2021;47(03n04):49-60. doi:10.1142/S1682648522500020
4. Canonne AM, Menard M, Maurey C, et al. Comparison of C-reactive protein concentrations in dogs with Bordetella bronchiseptica infection and aspiration bronchopneumonia. J Vet Intern Med. 2021;35(3):1519-1524. doi:10.1111/jvim.16091
5. Fernandes Rodrigues N, Giraud L, Bolen G, et al. Comparison of lung ultrasound, chest radiographs, C-reactive protein, and clinical findings in dogs treated for aspiration pneumonia. J Vet Intern Med. 2022;36(2):743-752. doi:10.1111/jvim.16379
6. Foster JD, Sample S, Kohler R, Watson K, Muir P, Trepanier LA. Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy. J Vet Intern Med. 2014;28(3):905-911. doi:10.1111/jvim.12351
7. Griebsch C, Arndt G, Raila J, Schweigert FJ, Kohn B. C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia. Vet Clin Path. 2009;38(4):421-425. doi:10.1111/j.1939-165X.2009.00146.x
8. Chase D, McLauchlan G, Eckersall PD, Pratschke J, Parkin T, Pratschke K. Acute phase protein levels in dogs with mast cell tumours and sarcomas. Vet Rec. 2012;170(25):648. doi:10.1136/vr.100401
9. Tecles F, Caldín M, Zanella A, et al. Serum acute phase protein concentrations in female dogs with mammary tumors. J Vet Diagn Invest. 2009;21(2):214-219. doi:10.1177/104063870902100206
10. Heilmann RM, Steiner JM. Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs. J Vet Intern Med. 2018;32(5): 1495-1508. doi:10.1111/jvim.15247
11. Sato T, Ohno K, Tamamoto T, et al. Assessment of severity and changes in C-reactive protein concentration and various biomarkers in dogs with pancreatitis. J Vet Med Sci. 2017;79(1):35-40. doi:10.1292/jvms.16-0009
12. Dabrowski R, Kostro K, Lisiecka U, Szczubiał M, Krakowski L. Usefulness of C-reactive protein, serum amyloid A component, and haptoglobin determinations in bitches with pyometra for monitoring early post-ovariohysterectomy complications. Theriogenology. 2009;72(4):471-476. doi:10.1016/j.theriogenology.2009.03.017
13. Kanno N, Hayakawa N, Suzuki S, Harada Y, Yogo T, Hara Y. Changes in canine C-reactive protein levels following orthopaedic surgery: a prospective study. Acta Vet Scand. 2019;61(1):33. doi:10.1186/s13028-019-0468-y
14. Tuna GE, Ay CD, Ulutas PA, Ulutas B. Serum procalcitonin and C-reactive protein concentrations in dogs with degenerative mitral valve disease and infective endocarditis. Vet Arhiv. 2022;92(3):311-321. doi:10.24099/vet.arhiv.1554
15. Buser FC, Schweighauser A, Im Hof-Gut M, et al. Evaluation of C-reactive protein and its kinetics as a prognostic indicator in canine leptospirosis. J Small Anim Pract. 2019;60(8):477-485. doi:10.1111/jsap.13004
16. Trub SA, Bush WW, Paek M, Cuff DE. Use of C-reactive protein concentration in evaluation of diskospondylitis in dogs. J Vet Intern Med. 2021;35(1):209-216. doi:10.1111/jvim.15981
17. Asawakarn S, Taweethavonsawat P. Characterization of serum protein electrophoresis patterns and C-reactive protein in canine tick-borne diseases. Vet World. 2021;14(8):2150-2154. doi:10.14202/vetworld.2021.2150-2154
18. Viitanen SJ, Laurila HP, Lilja-Maula LI, Melamies MA, Rantala M, Rajamäki MM. Serum C-reactive protein as a diagnostic biomarker in dogs with bacterial respiratory diseases. J Vet Intern Med. 2014;28(1):84-91. doi:10.1111/jvim.12262
19. Viitanen SJ, Lappalainen AK, Christensen MB, Sankari S, Rajamäki MM. The utility of acute-phase proteins in the assessment of treatment response in dogs with bacterial pneumonia. J Vet Intern Med. 2017;31(1):124-133. doi:10.1111/jvim.14631
20. Yokoe M, Takada T, Mayumi T, et al. Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci. 2015;22(6):405-432. doi:10.1002/jhbp.259
21. Meher S, Mishra TS, Sasmal PK, et al. Role of biomarkers in diagnosis and prognostic evaluation of acute pancreatitis. J Biomark. 2015;2015:1-13. doi:10.1155/2015/519534
22. Khanna AK, Meher S, Prakash S, et al. Comparison of Ranson, Glasgow, MOSS, SIRS, BISAP, APACHE-II, CTSI scores, IL-6, CRP, and procalcitonin in predicting severity, organ failure, pancreatic necrosis, and mortality in acute pancreatitis. HPB Surg. 2013;2013:1-10. doi:10.1155/2013/367581
23. Keany KM, Fosgate GT, Perry SM, Stroup ST, Steiner JM. Serum concentrations of canine pancreatic lipase immunoreactivity and C-reactive protein for monitoring disease progression in dogs with acute pancreatitis. J Vet Intern Med. 2021;35(5):2187-2195. doi:10.1111/jvim.16218
24. Griebsch C, Arndt G, Kohn B. Evaluation of different prognostic markers including C-reactive protein in canine autoimmune hemolytic anemia. Berl Munch Tierarztl Wochenschr. 2010;123(3-4):160-168. doi:10.2376/0005-9366-123-160
25. Yamamoto S, Shida T, Miyaji S, et al. Changes in serum C-reactive protein levels in dogs with various disorders and surgical traumas. Vet Res Commun. 1993;17(2):85-93. doi:10.1007/BF01839236
26. Ceron JJ, Eckersall PD, Martýnez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Path. 2005;34(2):85-99. doi:10.1111/j.1939-165x.2005.tb00019.x
27. Nakamura M, Takahashi M, Ohno K, et al. C-reactive protein concentration in dogs with various diseases. J Vet Med Sci. 2008;70(2):127-131. doi:10.1292/jvms.70.127
28. Hindenberg S, Bauer N, Moritz A. Extremely high canine C-reactive protein concentrations > 100 mg/l – prevalence, etiology and prognostic significance. BMC Vet Res. 2020;16(1):147. doi:10.1186/s12917-020-02367-7
29. Torrie PAG, Leonidou A, Harding IJ, Wynne Jones G, Hutchinson MJ, Nelson IW. Admission inflammatory markers and isolation of a causative organism in patients with spontaneous spinal infection. Ann R Coll Surg Engl. 2013;95(8):604-608. doi:10.1308/rcsann.2013.95.8.604
30. Loibl M, Stoyanov L, Doenitz C, et al. Outcome-related co-factors in 105 cases of vertebral osteomyelitis in a tertiary care hospital. Infection. 2014;42(3):503-510. doi:10.1007/s15010-013-0582-0
31. Nye G, Liebel F, Harcourt-Brown T. C-reactive protein in dogs with suspected bacterial diskospondylitis: 16 cases (2010–2019). Vet Rec Open. 2020;7(1):e000386. doi:10.1136/vetreco-2019-000386
32. Bathen-Noethen A, Carlson R, Menzel D, Mischke R, Tipold A. Concentrations of acute-phase proteins in dogs with steroid responsive meningitis-arteritis. J Vet Intern Med. 2008;22(5):1149-1156. doi:10.1111/j.1939-1676.2008.0164.x
33. Covin MA, Steiner JM. Measurement and clinical applications of C-reactive protein in gastrointestinal diseases of dogs. Vet Clin Path. 2022;50(Suppl 1): 29-36. doi:10.1111/vcp.13100
